6.18 Tuberculosis Surveillance and Control Program Flashcards
Elements of TB Control Program
Tuberculosis screening Preventative therapy Tuberculosis case identification Tuberculosis patient management contact investigation
Approved Tuberculin Skin Test
Mantoux Method Purified Protein Derivative (PPD) - Tubersol (preferred) - Aplisol (alternative) 1/4in-1/2in needle 27 gauge
IGRA
Interferon Gamma Release Assays to detect TB
FDA approved
Quanti-Feron TB Gold
QFT
is designed for use in place of, not addition to a TST
Mycobacterium Tuberculosis
bacteria that cause latent TB infection and active TB disease
Active TB disease
illness with TB bacteria are multiplying and attacking the body
Latent TB infection
a condition that TB bacteria are alive but inactive in the body
cant spread to others, dont feel sick
TB Skin Test
a test used to find out if you have TB
TB Blood test
new test that uses blood to test for TB
BCG
TB Vaccine named after French scientist, Calmette and Guerin
RARELY used in US. often given to infants and small children in other countries where TB is common
Direct Observed Therapy
DOT
helping patient take their meds for TB
Latent Tuberculosis Infection LTBI Treatment
Isoniazid (INH) Rifapentine (RPT) Oral weekly dose 15mg/kg (900mg max) 10-14kg 300mg 14.1-25kg 450mg 25.1-32kg 600mg 32.1-49.9kg 750mg >50kg 900mg for three months
Rifampin (RIF)
10mg/kg 600mg max
4 months
When a person has a history of active TB they must provide documentation of:
clinical evaluations
hospitalizations
diagnosis
treatment
When do people get screened for TB?
PHA
What is the TB screening documented on?
NAVMED 6224/8